semaglutide is a peptide Structure of semaglutide. The analog of human glucagon-like peptide-1 Semaglutide | Research Peptide

Separating the two doses, or moving levothyroxine to bedtime, will reduce the likelihood of medication interactions, helping your thyroxine levels remain stable

Long-term success follows systems, not just drugs: studies and program reports show roughly 75% of participants experience significant weight loss on GLP-1 medications, and about 60% maintain weight loss long term when behavioral anchors and monitoring are included, so tracking the first 8 to 12 weeks is critical

3.2% in the placebo group, according to the researchers

Ensure you drink plenty of fluids to avoid kidney problems, especially when starting treatment or increasing your dose

Semaglutide is positioned as a long-term intervention rather than a short-term solution, requiring sustained oversight to maintain safety and effectiveness